Abstract
Thromboxane A2 (TxA2) may aggravate myocardial ischemia by inducing vasoconstriction and platelet aggregation in small coronary vessels, whereas prostacyclin (PGI2) counteracts these effects. Acetylsalicylic acid (ASA) inhibits the formation of TxA2 as well as PGI2, whereas dazoxiben, a thromboxane synthetase inhibitor, reduces TxA2 formation selectively. In 25 patients with coronary artery disease, 2 identical atrial pacing stress tests were performed: before and after the administration of dazoxiben (200 mg) in 15 patients and before and after ASA (250 mg) in 10. The ischemic response, quantified by coronary sinus and aortic lactate levels and by ST depression, was significantly reduced after administration of dazoxiben (p less than 0.02) but not after ASA. Heart rate at rest, myocardial extraction of free fatty acids and the arteriovenous oxygen difference was unaffected by medication. Both drugs reduced TxB2 levels to the same extent, whereas collagen-induced aggregation was more reduced after ASA than after dazoxiben. The effect of dazoxiben on ischemia was probably a result of inhibited TxA2 and preserved PGI2 production, which increased blood flow to ischemic regions.
References
Aug 1, 1977·British Heart Journal·G JacksonS Oram
Jan 1, 1979·Circulation·G Kugler
Dec 1, 1976·Scandinavian Journal of Clinical and Laboratory Investigation·H Vik-Mo, O D Mjös
Mar 1, 1972·Atherosclerosis·J W Haerem
Jul 1, 1971·The Journal of Clinical Investigation·O D Mjos
Jul 1, 1970·Analytical Biochemistry·R J Ho
Jul 1, 1969·Circulation·J O ParkerR B Case
Sep 1, 1983·The American Journal of Cardiology·E Thaulow
Feb 1, 1983·Scandinavian Journal of Clinical and Laboratory Investigation·H IhlenE Thaulow
Jan 1, 1983·British Journal of Clinical Pharmacology·P S KiffV V Kakkar
Jan 1, 1983·British Journal of Clinical Pharmacology·I HuttonJ F Davidson
Jan 1, 1983·British Journal of Clinical Pharmacology·S J Coker, J R Parratt
Jan 1, 1983·British Journal of Clinical Pharmacology·S E BurkeJ B Smith
Dec 1, 1981·Circulation·M TadaH Abe
Jun 1, 1980·Circulation·R I LewyJ B Smith
Citations
Jan 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·L N MaslovIu B Lishmanov
Dec 1, 1989·Cardiovascular Drugs and Therapy·B Stein, V Fuster
Jan 20, 1987·European Journal of Pharmacology·C L Wainwright, J R Parratt
Oct 1, 1989·Journal of the American College of Cardiology·B SteinJ H Chesebro
Dec 1, 1986·British Heart Journal·D P De BonoD F Woodings
Jul 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·G M PieperG J Gross
Mar 3, 1998·Blood Reviews·J E Joseph, S J Machin
Dec 1, 1986·Journal of Cardiac Surgery·W J GreeleyW D Watkins
Dec 1, 1987·Thrombosis Research·W TerresW Bleifeld
Jan 15, 1986·Thrombosis Research·Z TerashitaS Terao
May 1, 1985·Human Toxicology·E IrisarriY Rabémampianina
Oct 1, 1985·Circulation·P M Vanhoutte, D S Houston
Dec 1, 1985·Circulation·G A FitzGeraldA K Pedersen
Dec 1, 1985·Circulation·R T BrittainD Jack
Oct 16, 1986·The New England Journal of Medicine·D J FitzgeraldG A FitzGerald
Jan 1, 1987·Pharmacotherapy·R E Nitz, V B Fiedler
Aug 1, 1987·Journal of Cardiothoracic Anesthesia·W J GreeleyJ G Reves